Knight Therapeutics
TSX:GUD
C$ 7,54
+ C$0,08 (1,07%)
7,54 C$
+C$0,08 (1,07%)
End-of-day quote: 04/24/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

C$0,02
Earnings Per Share
C$4,53
Revenue Per Share
44,49%
Gross Margin %
C$0,73 B
Market Cap
C$0,05 B
Long-Term Debt
Earnings Per Share
C$0,02
Revenue Per Share
C$4,53
Gross Margin %
44,49%
Market Cap
C$0,73 B
Long-Term Debt
C$0,05 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
EPS Earnings Per Share C$0,02 C$0,04 C$-0,07 C$0,31 C$0,14 C$0,22 C$0,19 C$0,14 C$0,15 C$0,17 C$0,11 C$0,03 C$0,05
Earnings Earnings C$1,99M C$4,00M C$-7,08M C$34,14M C$16,38M C$28,33M C$25,72M C$20,00M C$21,42M C$24,26M C$11,38M C$2,72M C$0,00M
RPS Revenue Per Share C$4,53 C$3,71 C$3,24 C$2,67 C$2,08 C$1,55 C$0,35 C$0,09 C$0,06 C$0,04 C$0,01 C$0,00 N/A
Revenue Revenue C$450,09M C$371,30M C$328,20M C$293,56M C$243,48M C$199,52M C$47,46M C$12,50M C$8,63M C$5,94M C$1,04M C$0,37M C$0,00M
OCF Operating Cash Flow C$41,26M C$36,28M C$35,94M C$40,48M C$44,62M C$-12,21M C$4,60M C$-5,74M C$23,46M C$14,74M C$7,64M C$0,80M C$0,00M
FCF Free Cash Flow C$39,90M C$33,81M C$29,00M C$37,60M C$40,79M C$-17,58M C$4,49M C$-5,94M C$0,00M C$14,73M C$7,34M C$0,73M C$0,00M
OM Operating Margin -0,52% 1,99% 1,94% -5,81% -5,27% -13,19% -9,77% -46,26% -103,15% -131,92% 0,00% 0,00% 0,00%
GM % Gross Margin % 44,49% 46,97% 46,51% 47,03% 47,40% 40,94% 56,72% 82,23% 81,64% 73,91% 58,73% 100,00% 0,00%
FCFS Free Cash Flow Per Share C$0,35 C$0,05 C$0,24 C$0,17 C$-1,44 C$-0,25 C$0,01 C$-0,07 C$0,16 C$0,04 C$0,08 C$2,45 C$0,00
LT Debt Long-Term Debt C$51,17M C$25,90M C$44,02M C$52,40M C$9,27M N/A C$5,02M N/A N/A N/A N/A N/A N/A
Sha. Stocks 99,34M 100,05M 101,17M 110,13M 117,03M 128,76M 135,38M 142,85M 142,81M 142,71M 103,47M 90,82M 0M
×